1
CARDIOVASCULAR
hamburger

How It Works

Full MagLev™ Flow Technology: Easy on the blood

Designed for optimal hemocompatibility,1,2 Full MagLev Flow Technology can result in low hemolysis1 and low device-related thrombosis (2.5%).1,2

Watch this video to see how Full MagLev Flow Technology works.

Illustration of the CentriMag Acute Circulatory Support System’s Full Maglev Flow Technology

Reduced blood trauma,3 minimized turbulence, maintained stability

Full MagLev Flow Technology provides a contact-free environment that features:

  • A free-floating magnetically levitated rotor to prevent surface-to-surface contact that could cause blood trauma
  • Wide blood-flow pathways and absence of seals, bearings and valves to minimize blood turbulence and stasis
  • Automatic rotor positioning that adjusts 50,000 times per second to maintain stable and consistent blood flow

 

Illustration demonstrating free-floating magnetically levitated rotor and blood pathways details.

  • Manuals & Technical Resources
  • Cardiovascular Products
  • Customer Service

References

  1. John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag™ ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. http://dx.doi.org/10.1016/j.jtcvs.2010.03.046
  2. John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. http://dx.doi.org/10.1016/j.jtcvs.2007.01.085
  3. Zhang, J., Gellman, B., Koert, A., Dasse, K. A., Gilbert, R. J., Griffith, B. P., & Wu, Z. J. (2006). Computational and experimental evaluation of the fluid dynamics and hemocompatibility of the CentriMag blood pump. Artificial Organs, 30(3), 168-177. http://dx.doi.org/10.1111/j.1525-1594.2006.00203.x
INDICATIONS, SAFETY & WARNINGS

MAT-2006911 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2019 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.